Trials / Completed
CompletedNCT06576427
Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Jupiter Endovascular · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.
Detailed description
The study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism. The Vertex Pulmonary Embolectomy System is intended for the non-surgical removal of emboli and thrombi from blood vessels as a means for treating pulmonary embolism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vertex Pulmonary Embolectomy System | Use of Vertex Pulmonary Embolectomy System to treat pulmonary embolism. |
Timeline
- Start date
- 2024-10-15
- Primary completion
- 2026-02-04
- Completion
- 2026-03-03
- First posted
- 2024-08-28
- Last updated
- 2026-04-06
Locations
23 sites across 4 countries: United States, Austria, Poland, Switzerland
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06576427. Inclusion in this directory is not an endorsement.